SlideShare a Scribd company logo
By
Islam Shallal.
Wednesday. April 3, 2012
Pharm D student.
1. Aim of the work.
2. Patients and methods.
3. Results and discussion.
4. Limitations.
5. Recommendations.
Detection and evaluation of drug related
problems commonly encountered during drug
prescription in hospitalized Internal medicine
patients at General Hospital of Zagazig.
Thus an establishment of recommendations
and advices for inappropriate medication use in
the hospital would be performed.
 Eighty patients were included in this study
randomly, from the medical record section
of the Internal medicine department.
 The study was conducted retrospectively.
 No exclusion criteria as any patients at IM
department entered in this study.
Data collection sheet.
• Patient history.
• chief compliant.
• Currents diseases.
• Complete physical examination.
• Laboratory investigations.
• Treatment prescribed by treating physician.
1- Drug -drug interactions.
2-Wrong dose : (high dose/ low dose/ inappropriate
frequency)
3- Wrong or inappropriate drugs: (Drugs
duplications,Wrong drug, Drugs written without
medical problem stated)
4- Drug needed(Medical problem but no drug is
prescribed, Medication is unavailable, Prophylaxis
drugs )
5- Writing problems.
1) Drug interactions . Use Lexi.comp program.
2) Other encountered medications errors
a) detect medical conditions
b) read the guidelines from textbooks then
uptodate site
3) Writing problems and unavailable medications
are detected at time of data collection.
Morbidity Number Percentage
Chronic liver diseases 24 30.0%
hypertension 22 27.5%
Diabetes 21 26.2%
Renal failure 13 16.2%
Stroke 12 15.0%
Respiratory disease 12 15.0%
Ischemic heart disease 10 12.5%
Anemia 10 12.5%
Arrhythmia 3 3.7%
Heart failure 2 2.5%
Drugs’ group No. ( %)
Antibiotic drugs. 68(85%)
Anti acids drugs. 47(58.7%)
IV fluids drugs. 39(48.7%)
Anticoagulants. 27(33.7%)
Antihypertensive drugs. 21(26.2%)
Hepatic support drugs. 19(23.7%)
Anti hemorrhagic drugs. 16(20%)
Heart diseases drugs. 16(20%)
Anti hyperlipidemia drugs. 15(18.7%)
Analgesic and anti-inflammatory
drugs.
15(18.7%)
Patient No. Number. Percentage.
Total No. of patients
with drugs
interactions
53 66.2 %
Total No of patients
without drug
interactions.
27 33.7%
It was calculated that 124 drug-drug
interactions were encountered among the 53
patients who were suffering drug- drug
interactions
Severity rating No. Perecentage.
Major 23 18.5
Moderate 100 80.6
Minor 1 0.8
Reliability No. Percentage.
Excellent. 15 12.0
Good. 32 25.8
Fair. 67 54.0
Poor. 10 8.0
classifications of drug interactions presented in the
studied patients according to their reliability:
Action needed. No. Percentage.
X: avoid combination. 1 0.8
D: consider drug
modifications.
13 10.4
C: monitor therapy
closely.
107 86.2
B: no action needed. 3 2.5
It is so clear most of drug interactions were
C in significance, moderate in severity, and fair
in documentation
Age Drug
interaction
(+ve)
Drug
interactions
(-ve)
18-30 2(28.5) 5(71.5)
31-40 1(50.0) 1(50.0)
41-50 13(72.3) 5(27.7)
51-60 18(72) 7(28)
61-70 8(61.5) 5(38.5)
71-80 9(81.8) 2(18.2)
81-90 2(50.0) 2(50.0)
No of prescribed
drugs.
Drug interactions
(+ve)
Drug interactions
(-ve)
1 - -
2 0(0%) 1(100%)
3 - -
4 - -
5 1(33.3%) 2(66.7%)
6 3(42.8%) 4(57.2%)
7 5(45.5%) 6(54.5%)
8 5(71.4%) 2(28.5%)
9 11(73.3%) 4(26.6%)
10 8(80.0%) 2(20.0%)
11 12(85.8%) 2(14.2%)
12 3(75%) 1(25%)
13 3(75%) 1(25%)
14 2(100%) 0(0.0%)
Errors. No. of patients Percentage
high dose 11 13.7
Low dose 23 28.7
Inappropriate frequency 39 48.7
Errors. No. of patients Percentage
Duplication of the
therapy.
16 20.0
Wrong drug. 8 10.0
Drug written without
medical problem stated
54 67.5
wrong and inappropriate drugs presented in studied patients:
Error. No. of patients Percentage.
Unavailable medication. 23 28.7
Medical problem but no
drug written.
34 42.5
Prophylaxis/prevention
drugs.
20 25.0
Error. No. of patients Percentage.
misspelling 45 56.2
Bad hand writing 40 50.0
Inappropriate
abbreviation.
47 58.7
Writing problems distribution in patients:
1) no intervention was done as it retrospective
observational study.
2) depended mainly on an observational experience
which is more subjective and may be a source of bias.
3) The study was restricted to one hospital; therefore it
cannot be assumed that the results are representative
of other MOH hospitals.
4) Many of medications orders did not contain
complete information about current diseases and
some demographic data like weight and pregnancy
status.
1) It is recommended to include the clinical pharmacist
in the overseeing of the quality of the entire drug
distribution chain, before prescribing, drug choice,
dispensing and preparation to the administration of
the drugs
2) Using documented drug information data, books,
PDA, or database to be able to know accurate and up-
to-date data about prescribed drugs (dose, side
effects, drug interactions, precautions,
contraindications).
3) Clinical pharmacist has a role in implementing and
updating the guidelines for different disease state .
4) It is advisable to use drug therapy only when it is
essential and assess risk benefit ratio, thus the number
of drugs prescribed should be kept to a minimum by
health care providers
5) Prescription orders should specify indication for use
(e.g., for cough).
6) It is preferable to avoid the use of abbreviations.
Prescriptions should always include specific and clear
instructions for use and avoid "As Directed".
7) It is recommended to All prescriptions must be legible
and in plain language. Prescribers, whenever possible
should adopt a direct computerized order entry system
which will aid to decrease drug related problems.
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF

More Related Content

What's hot

Who causality assessment scale
Who causality assessment scaleWho causality assessment scale
Who causality assessment scale
SHARIQUE RAZA
 
stages of the medication use process and medication errors
 stages of the medication use process and medication errors stages of the medication use process and medication errors
stages of the medication use process and medication errors
MEEQAT HOSPITAL
 
Rational use of medicines for BPH
Rational use of medicines for BPHRational use of medicines for BPH
Rational use of medicines for BPH
Pravin Prasad
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
Sams Pharmacy
 
Medsreconpaper
MedsreconpaperMedsreconpaper
Medsreconpaper
prempanigrahi
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Divjyot Kaur
 
PolyPharmacy Prevention in Older Populations
PolyPharmacy Prevention in Older Populations PolyPharmacy Prevention in Older Populations
PolyPharmacy Prevention in Older Populations
P.C.D.I Healthcare and Consultants of Texas L.L.C.
 
Use of alternative medicine
Use of alternative medicineUse of alternative medicine
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2
maykamen
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
Dr. Prashant Shukla
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.
Mdshams244
 
Dispensing error
Dispensing errorDispensing error
Dispensing error
Alina M. Sánchez
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
Ruella D'Costa Fernandes
 
Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.
Dr. Sharad Chand
 
Medication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice LectureMedication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice Lecture
Shaheed Benazir Bhutto University Sheringal
 
Presentation (1)
Presentation (1)Presentation (1)
Presentation (1)
subhasarada1977
 
Medication errors
Medication errors Medication errors
Medication errors
swarnank parmar
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
igiba
 
Prescription Patterns
Prescription PatternsPrescription Patterns
Prescription Patterns
Hafiz Saad Salman
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Satya Prakash Dixit
 

What's hot (20)

Who causality assessment scale
Who causality assessment scaleWho causality assessment scale
Who causality assessment scale
 
stages of the medication use process and medication errors
 stages of the medication use process and medication errors stages of the medication use process and medication errors
stages of the medication use process and medication errors
 
Rational use of medicines for BPH
Rational use of medicines for BPHRational use of medicines for BPH
Rational use of medicines for BPH
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Medsreconpaper
MedsreconpaperMedsreconpaper
Medsreconpaper
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
PolyPharmacy Prevention in Older Populations
PolyPharmacy Prevention in Older Populations PolyPharmacy Prevention in Older Populations
PolyPharmacy Prevention in Older Populations
 
Use of alternative medicine
Use of alternative medicineUse of alternative medicine
Use of alternative medicine
 
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.
 
Dispensing error
Dispensing errorDispensing error
Dispensing error
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.
 
Medication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice LectureMedication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice Lecture
 
Presentation (1)
Presentation (1)Presentation (1)
Presentation (1)
 
Medication errors
Medication errors Medication errors
Medication errors
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Prescription Patterns
Prescription PatternsPrescription Patterns
Prescription Patterns
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 

Viewers also liked

northamp3-151587_1
northamp3-151587_1northamp3-151587_1
northamp3-151587_1
Orlando Prestidge
 
Editing analysis Powerpoint
Editing analysis Powerpoint Editing analysis Powerpoint
Editing analysis Powerpoint
lightening123
 
Music video textual analysis
Music video textual analysisMusic video textual analysis
Music video textual analysis
laulmillsxx
 
Resolving Investment Fraud Disputes
Resolving Investment Fraud DisputesResolving Investment Fraud Disputes
Resolving Investment Fraud Disputes
blocklandsman
 
Sponsorship Brochure
Sponsorship BrochureSponsorship Brochure
Sponsorship Brochure
Vamsi Kunapuli
 
Apprenticeship vacancies-19-11-15
Apprenticeship vacancies-19-11-15Apprenticeship vacancies-19-11-15
Apprenticeship vacancies-19-11-15
Harlow College
 
Löytyykö sijaa?
Löytyykö sijaa?Löytyykö sijaa?
Löytyykö sijaa?
Terttu Lajunen
 
Les Fulles del Parc - nº 82
Les Fulles del Parc - nº 82Les Fulles del Parc - nº 82
Les Fulles del Parc - nº 82
ampaparcguinardo
 
SAJNA RESCUME
SAJNA RESCUMESAJNA RESCUME
SAJNA RESCUME
Sajna Ali
 
Employee overview document
Employee overview documentEmployee overview document
Employee overview document
Madhumita Ghosh
 
Android slides
Android slidesAndroid slides
Android slides
Victor Solis
 
INNOVATIVE LESSON PLAN
INNOVATIVE LESSON PLANINNOVATIVE LESSON PLAN
INNOVATIVE LESSON PLAN
Saranyareny143
 
How do regulated and unregulated labor markets respond to shocks? Evidence fr...
How do regulated and unregulated labor markets respond to shocks? Evidence fr...How do regulated and unregulated labor markets respond to shocks? Evidence fr...
How do regulated and unregulated labor markets respond to shocks? Evidence fr...
Stockholm Institute of Transition Economics
 
Es145 02-Especial perfumes-tipo de perfume
Es145 02-Especial perfumes-tipo de perfumeEs145 02-Especial perfumes-tipo de perfume
Es145 02-Especial perfumes-tipo de perfume
Bint
 
02112015 Modelling Collective Defined Contribution Schemes
02112015 Modelling Collective Defined Contribution Schemes02112015 Modelling Collective Defined Contribution Schemes
02112015 Modelling Collective Defined Contribution Schemes
Sarah Luheshi
 

Viewers also liked (16)

northamp3-151587_1
northamp3-151587_1northamp3-151587_1
northamp3-151587_1
 
Editing analysis Powerpoint
Editing analysis Powerpoint Editing analysis Powerpoint
Editing analysis Powerpoint
 
86312
8631286312
86312
 
Music video textual analysis
Music video textual analysisMusic video textual analysis
Music video textual analysis
 
Resolving Investment Fraud Disputes
Resolving Investment Fraud DisputesResolving Investment Fraud Disputes
Resolving Investment Fraud Disputes
 
Sponsorship Brochure
Sponsorship BrochureSponsorship Brochure
Sponsorship Brochure
 
Apprenticeship vacancies-19-11-15
Apprenticeship vacancies-19-11-15Apprenticeship vacancies-19-11-15
Apprenticeship vacancies-19-11-15
 
Löytyykö sijaa?
Löytyykö sijaa?Löytyykö sijaa?
Löytyykö sijaa?
 
Les Fulles del Parc - nº 82
Les Fulles del Parc - nº 82Les Fulles del Parc - nº 82
Les Fulles del Parc - nº 82
 
SAJNA RESCUME
SAJNA RESCUMESAJNA RESCUME
SAJNA RESCUME
 
Employee overview document
Employee overview documentEmployee overview document
Employee overview document
 
Android slides
Android slidesAndroid slides
Android slides
 
INNOVATIVE LESSON PLAN
INNOVATIVE LESSON PLANINNOVATIVE LESSON PLAN
INNOVATIVE LESSON PLAN
 
How do regulated and unregulated labor markets respond to shocks? Evidence fr...
How do regulated and unregulated labor markets respond to shocks? Evidence fr...How do regulated and unregulated labor markets respond to shocks? Evidence fr...
How do regulated and unregulated labor markets respond to shocks? Evidence fr...
 
Es145 02-Especial perfumes-tipo de perfume
Es145 02-Especial perfumes-tipo de perfumeEs145 02-Especial perfumes-tipo de perfume
Es145 02-Especial perfumes-tipo de perfume
 
02112015 Modelling Collective Defined Contribution Schemes
02112015 Modelling Collective Defined Contribution Schemes02112015 Modelling Collective Defined Contribution Schemes
02112015 Modelling Collective Defined Contribution Schemes
 

Similar to THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF

A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
M.Arumuga Vignesh
 
Patterns of Prescription Writing in Psychiatric Clinics
Patterns of Prescription Writing in Psychiatric ClinicsPatterns of Prescription Writing in Psychiatric Clinics
Patterns of Prescription Writing in Psychiatric Clinics
Hafiz Saad Salman
 
Managing medicine safety
Managing medicine safetyManaging medicine safety
Managing medicine safety
Phr. Shyam Kumar Adhikari
 
Modeling Opioid Risk
Modeling Opioid RiskModeling Opioid Risk
Modeling Opioid Risk
Paul Coelho, MD
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
ashfaq22
 
1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx
yohanneswobie2
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
maneeshkumar reddy
 
Drug Utilization research
Drug Utilization researchDrug Utilization research
Drug Utilization research
dineshmeena53
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptx
Anusha Are
 
Presentation1
Presentation1Presentation1
Presentation1
Dr Shubham Painoli
 
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
Jing Zang
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
Ahmad Ali
 
Article 1527760801
Article 1527760801 Article 1527760801
Article 1527760801
vallampati prudhvi
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
Bimal Magar
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
MuungoLungwani
 
Optimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College LondonOptimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College London
KCL_commsunit
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
sunayanamali
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
UVAS
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
An observational study of medicationadministration errors in.docx
An observational study of medicationadministration errors in.docxAn observational study of medicationadministration errors in.docx
An observational study of medicationadministration errors in.docx
daniahendric
 

Similar to THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF (20)

A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 
Patterns of Prescription Writing in Psychiatric Clinics
Patterns of Prescription Writing in Psychiatric ClinicsPatterns of Prescription Writing in Psychiatric Clinics
Patterns of Prescription Writing in Psychiatric Clinics
 
Managing medicine safety
Managing medicine safetyManaging medicine safety
Managing medicine safety
 
Modeling Opioid Risk
Modeling Opioid RiskModeling Opioid Risk
Modeling Opioid Risk
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
 
1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Drug Utilization research
Drug Utilization researchDrug Utilization research
Drug Utilization research
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptx
 
Presentation1
Presentation1Presentation1
Presentation1
 
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
Article 1527760801
Article 1527760801 Article 1527760801
Article 1527760801
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
 
Optimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College LondonOptimising Medicine Use, Professor Graham Davies, King's College London
Optimising Medicine Use, Professor Graham Davies, King's College London
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
An observational study of medicationadministration errors in.docx
An observational study of medicationadministration errors in.docxAn observational study of medicationadministration errors in.docx
An observational study of medicationadministration errors in.docx
 

THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF

  • 1. By Islam Shallal. Wednesday. April 3, 2012 Pharm D student.
  • 2. 1. Aim of the work. 2. Patients and methods. 3. Results and discussion. 4. Limitations. 5. Recommendations.
  • 3. Detection and evaluation of drug related problems commonly encountered during drug prescription in hospitalized Internal medicine patients at General Hospital of Zagazig. Thus an establishment of recommendations and advices for inappropriate medication use in the hospital would be performed.
  • 4.  Eighty patients were included in this study randomly, from the medical record section of the Internal medicine department.  The study was conducted retrospectively.  No exclusion criteria as any patients at IM department entered in this study.
  • 5. Data collection sheet. • Patient history. • chief compliant. • Currents diseases. • Complete physical examination. • Laboratory investigations. • Treatment prescribed by treating physician.
  • 6. 1- Drug -drug interactions. 2-Wrong dose : (high dose/ low dose/ inappropriate frequency) 3- Wrong or inappropriate drugs: (Drugs duplications,Wrong drug, Drugs written without medical problem stated) 4- Drug needed(Medical problem but no drug is prescribed, Medication is unavailable, Prophylaxis drugs ) 5- Writing problems.
  • 7. 1) Drug interactions . Use Lexi.comp program. 2) Other encountered medications errors a) detect medical conditions b) read the guidelines from textbooks then uptodate site 3) Writing problems and unavailable medications are detected at time of data collection.
  • 8. Morbidity Number Percentage Chronic liver diseases 24 30.0% hypertension 22 27.5% Diabetes 21 26.2% Renal failure 13 16.2% Stroke 12 15.0% Respiratory disease 12 15.0% Ischemic heart disease 10 12.5% Anemia 10 12.5% Arrhythmia 3 3.7% Heart failure 2 2.5%
  • 9. Drugs’ group No. ( %) Antibiotic drugs. 68(85%) Anti acids drugs. 47(58.7%) IV fluids drugs. 39(48.7%) Anticoagulants. 27(33.7%) Antihypertensive drugs. 21(26.2%) Hepatic support drugs. 19(23.7%) Anti hemorrhagic drugs. 16(20%) Heart diseases drugs. 16(20%) Anti hyperlipidemia drugs. 15(18.7%) Analgesic and anti-inflammatory drugs. 15(18.7%)
  • 10. Patient No. Number. Percentage. Total No. of patients with drugs interactions 53 66.2 % Total No of patients without drug interactions. 27 33.7% It was calculated that 124 drug-drug interactions were encountered among the 53 patients who were suffering drug- drug interactions
  • 11. Severity rating No. Perecentage. Major 23 18.5 Moderate 100 80.6 Minor 1 0.8 Reliability No. Percentage. Excellent. 15 12.0 Good. 32 25.8 Fair. 67 54.0 Poor. 10 8.0 classifications of drug interactions presented in the studied patients according to their reliability:
  • 12. Action needed. No. Percentage. X: avoid combination. 1 0.8 D: consider drug modifications. 13 10.4 C: monitor therapy closely. 107 86.2 B: no action needed. 3 2.5 It is so clear most of drug interactions were C in significance, moderate in severity, and fair in documentation
  • 13. Age Drug interaction (+ve) Drug interactions (-ve) 18-30 2(28.5) 5(71.5) 31-40 1(50.0) 1(50.0) 41-50 13(72.3) 5(27.7) 51-60 18(72) 7(28) 61-70 8(61.5) 5(38.5) 71-80 9(81.8) 2(18.2) 81-90 2(50.0) 2(50.0)
  • 14. No of prescribed drugs. Drug interactions (+ve) Drug interactions (-ve) 1 - - 2 0(0%) 1(100%) 3 - - 4 - - 5 1(33.3%) 2(66.7%) 6 3(42.8%) 4(57.2%) 7 5(45.5%) 6(54.5%) 8 5(71.4%) 2(28.5%) 9 11(73.3%) 4(26.6%) 10 8(80.0%) 2(20.0%) 11 12(85.8%) 2(14.2%) 12 3(75%) 1(25%) 13 3(75%) 1(25%) 14 2(100%) 0(0.0%)
  • 15. Errors. No. of patients Percentage high dose 11 13.7 Low dose 23 28.7 Inappropriate frequency 39 48.7 Errors. No. of patients Percentage Duplication of the therapy. 16 20.0 Wrong drug. 8 10.0 Drug written without medical problem stated 54 67.5 wrong and inappropriate drugs presented in studied patients:
  • 16. Error. No. of patients Percentage. Unavailable medication. 23 28.7 Medical problem but no drug written. 34 42.5 Prophylaxis/prevention drugs. 20 25.0 Error. No. of patients Percentage. misspelling 45 56.2 Bad hand writing 40 50.0 Inappropriate abbreviation. 47 58.7 Writing problems distribution in patients:
  • 17. 1) no intervention was done as it retrospective observational study. 2) depended mainly on an observational experience which is more subjective and may be a source of bias. 3) The study was restricted to one hospital; therefore it cannot be assumed that the results are representative of other MOH hospitals. 4) Many of medications orders did not contain complete information about current diseases and some demographic data like weight and pregnancy status.
  • 18. 1) It is recommended to include the clinical pharmacist in the overseeing of the quality of the entire drug distribution chain, before prescribing, drug choice, dispensing and preparation to the administration of the drugs 2) Using documented drug information data, books, PDA, or database to be able to know accurate and up- to-date data about prescribed drugs (dose, side effects, drug interactions, precautions, contraindications). 3) Clinical pharmacist has a role in implementing and updating the guidelines for different disease state .
  • 19. 4) It is advisable to use drug therapy only when it is essential and assess risk benefit ratio, thus the number of drugs prescribed should be kept to a minimum by health care providers 5) Prescription orders should specify indication for use (e.g., for cough). 6) It is preferable to avoid the use of abbreviations. Prescriptions should always include specific and clear instructions for use and avoid "As Directed". 7) It is recommended to All prescriptions must be legible and in plain language. Prescribers, whenever possible should adopt a direct computerized order entry system which will aid to decrease drug related problems.